SCHEMBL6993457

SCHEMBL6993457

O=C(O)N1CCC(=C2c3ccsc3CCn3ccnc32)CC1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HRH1 P35367 5/20 0.41
MAPK1 P28482 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 1/20 0.39
KMT2A Q03164 1/20 0.39
CYP2D6 P10635 1/20 0.35
CYP2C19 P33261 1/20 0.35
LMNA P02545 2/20 0.35
CHRM2 P08172 2/20 0.35
ADRA2A P08913 2/20 0.35
CHRM1 P11229 2/20 0.35
DRD2 P14416 2/20 0.35
ADRA2B P18089 2/20 0.35
DRD1 P21728 2/20 0.35
HTR2A P28223 2/20 0.35
HTR2C P28335 2/20 0.35
HTR7 P34969 2/20 0.35
DRD3 P35462 2/20 0.35
HTR3A P46098 2/20 0.35
ADRB2 P07550 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6990659 0.90 PTAFR (0.42) HRH1MAPK1MEN1MAPTKMT2A
Fumaric Acid SCHEMBL6996855 0.86 MAPK1 (0.48) HRH1MAPK1MEN1MAPTKMT2A
Fumaric Acid SCHEMBL6996858 0.86 MAPK1 (0.48) HRH1MAPK1MEN1MAPTKMT2A
SCHEMBL6990175 0.86 HRH1 (0.48) HRH1MAPK1MEN1MAPTKMT2A
Fumaric Acid SCHEMBL9282740 0.84 MAPK1 (0.60) HRH1MAPK1MEN1MAPTKMT2A
SCHEMBL6988823 0.83 HRH1 (0.52) HRH1MAPK1MEN1MAPTKMT2A
SCHEMBL6996608 0.79 HRH1 (0.41) HRH1MAPTCYP2D6CYP2C19LMNA
SCHEMBL6993068 0.76 MEN1 (0.31) HRH1MAPK1MEN1MAPTKMT2A
SCHEMBL6996281 0.76 OPRK1 (0.36) HRH1MAPK1MEN1MAPTKMT2A
Water SCHEMBL7169111 0.72 PTAFR (0.41) HRH1PTAFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0588859-B1 Imidazo[1,2-a](pyrrolo, thieno or furano)[3,2-d]azepine derivatives, compositions and methods of use JANSSEN PHARMACEUTICA NV (BE) 2003-08-13 EP claimed